GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Price-to-Tangible-Book

SNY (Sanofi) Price-to-Tangible-Book : (As of Oct. 31, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sanofi Price-to-Tangible-Book?

As of today (2024-10-31), Sanofi's share price is $52.88. Sanofi's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was $-1.74. Hence, Sanofi's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Sanofi's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Sanofi's highest Price to Tangible Book Ratio was 354.78. The lowest was 15.24. And the median was 36.06.

SNY's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.5
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Sanofi's share price is $52.88. Sanofi's Book Value per Sharefor the quarter that ended in Jun. 2024 was $31.27. Hence, Sanofi's P/B Ratio of today is 1.69.


Sanofi Price-to-Tangible-Book Historical Data

The historical data trend for Sanofi's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Price-to-Tangible-Book Chart

Sanofi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 35.45 360.36

Sanofi Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 35.45 - 360.36 -

Competitive Comparison of Sanofi's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Sanofi's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sanofi's Price-to-Tangible-Book falls into.



Sanofi Price-to-Tangible-Book Calculation

Sanofi's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=52.88/-1.739
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Sanofi Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sanofi's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Business Description

Address
46, avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

From GuruFocus

Q1 2023 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q2 2024 Sanofi SA Earnings Call Transcript

By GuruFocus Research 07-26-2024

Q3 2023 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024

Sanofi SA at TD Cowen Health Care Conference Transcript

By GuruFocus Research 03-25-2024

Sanofi SA Vaccines Investor Event Transcript

By GuruFocus Research 02-09-2024

Q4 2023 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q2 2023 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024